I think it's positive that BSI has requested a new investigation of 20 patients using current chemo agents with Oncosil.
Moving forward, according to Mr Kenny, Oncosil anticipates the first patient in this new subset of 20 to be recruited by March. Interesting times ahead and if the data further support the earlier results then the momentum will be positive.
(As a side note, lets assume that CE was granted. I can tell you now that uptake by physicians would potentially have been on the slow side as I'd imagine most would question the validity of any device that hasn't had recent efficacy and safety data).
OSL Price at posting:
7.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)